These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 24613827)

  • 21. Stem cells therapy for ALS.
    Mazzini L; Vescovi A; Cantello R; Gelati M; Vercelli A
    Expert Opin Biol Ther; 2016; 16(2):187-99. PubMed ID: 26558293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in stem cell research for Amyotrophic Lateral Sclerosis.
    Papadeas ST; Maragakis NJ
    Curr Opin Biotechnol; 2009 Oct; 20(5):545-51. PubMed ID: 19819686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in stem cell therapy for amyotrophic lateral sclerosis.
    Mazzini L; Ferrari D; Andjus PR; Buzanska L; Cantello R; De Marchi F; Gelati M; Giniatullin R; Glover JC; Grilli M; Kozlova EN; Maioli M; Mitrečić D; Pivoriunas A; Sanchez-Pernaute R; Sarnowska A; Vescovi AL;
    Expert Opin Biol Ther; 2018 Aug; 18(8):865-881. PubMed ID: 30025485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Human Pluripotent Stem Cells in Amyotrophic Lateral Sclerosis: From Biological Mechanism to Practical Implications.
    Ceccarelli L; Verriello L; Pauletto G; Valente M; Spadea L; Salati C; Zeppieri M; Ius T
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):114. PubMed ID: 38538275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advancing Stem Cell Therapy for Repair of Damaged Lung Microvasculature in Amyotrophic Lateral Sclerosis.
    Garbuzova-Davis S; Shell R; Mustafa H; Hailu S; Willing AE; Sanberg PR; Borlongan CV
    Cell Transplant; 2020; 29():963689720913494. PubMed ID: 32207340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy.
    O'Connor DM; Boulis NM
    Neurosci Lett; 2012 Oct; 527(2):78-84. PubMed ID: 22579818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyotrophic lateral sclerosis - looking for pathogenesis and effective therapy.
    Naganska E; Matyja E
    Folia Neuropathol; 2011; 49(1):1-13. PubMed ID: 21455838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell therapy in ALS: An update on preclinical and clinical studies.
    Sironi F; De Marchi F; Mazzini L; Bendotti C
    Brain Res Bull; 2023 Mar; 194():64-81. PubMed ID: 36690163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis.
    Suzuki M; Svendsen CN
    Trends Neurosci; 2008 Apr; 31(4):192-8. PubMed ID: 18329734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stem cells for ALS: An overview of possible therapeutic approaches.
    Czarzasta J; Habich A; Siwek T; Czapliński A; Maksymowicz W; Wojtkiewicz J
    Int J Dev Neurosci; 2017 Apr; 57():46-55. PubMed ID: 28088365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New therapeutic targets for amyotrophic lateral sclerosis.
    Kuzma-Kozakiewicz M; Kwiecinski H
    Expert Opin Ther Targets; 2011 Feb; 15(2):127-43. PubMed ID: 21133819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transplantation of mesenchymal stem cells in ALS.
    Mazzini L; Vercelli A; Ferrero I; Boido M; Cantello R; Fagioli F
    Prog Brain Res; 2012; 201():333-59. PubMed ID: 23186722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stem cells in amyotrophic lateral sclerosis: state of the art.
    Mazzini L; Vercelli A; Ferrero I; Mareschi K; Boido M; Servo S; Oggioni GD; Testa L; Monaco F; Fagioli F
    Expert Opin Biol Ther; 2009 Oct; 9(10):1245-58. PubMed ID: 19663719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
    Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
    Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death (Review).
    Martin LJ; Price AC; Kaiser A; Shaikh AY; Liu Z
    Int J Mol Med; 2000 Jan; 5(1):3-13. PubMed ID: 10601567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice.
    Kim H; Kim HY; Choi MR; Hwang S; Nam KH; Kim HC; Han JS; Kim KS; Yoon HS; Kim SH
    Neurosci Lett; 2010 Jan; 468(3):190-4. PubMed ID: 19879334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New therapy options for amyotrophic lateral sclerosis.
    Gordon P; Corcia P; Meininger V
    Expert Opin Pharmacother; 2013 Oct; 14(14):1907-17. PubMed ID: 23855817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Translating preclinical insights into effective human trials in ALS.
    DiBernardo AB; Cudkowicz ME
    Biochim Biophys Acta; 2006; 1762(11-12):1139-49. PubMed ID: 16713196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugs.
    Goyal NA; Mozaffar T
    Expert Opin Investig Drugs; 2014 Nov; 23(11):1541-51. PubMed ID: 24965719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.